GAROFALO ELIZABETH A. Insider Trades

Insider Trading History

Track insider trading activity for GAROFALO ELIZABETH A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Alector
Alector ALEC
Director
Holding Value $178k 118,650 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.5k 38,150 shares
$1.48
$1.50
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $711k 10,507 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$647k 12,100 shares
$53.46
$67.71
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $179k 2,645 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$141k 2,645 shares
$53.41
$67.71
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$141k 2,645 shares
$53.41
$67.71
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$176k 8,107 shares
$21.66
$25.92
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $868k 33,489 shares
Last Trade
May 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$176k 8,107 shares
$21.66
$25.92
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $415k 16,004 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$548k 25,315 shares
$21.66
$25.92
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $658k 25,382 shares
Last Trade
Sep 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$41.6k 1,600 shares
$25.98
$25.92
Alector
Alector ALEC
Director
Holding Value $135k 89,950 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.4k 9,450 shares
$1.63
$1.50
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.15M 17,012 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 17,012 shares
$30.73
$67.71
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$209k 9,387 shares
$22.29
$25.92
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $358k 13,793 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$307k 13,793 shares
$22.29
$25.92
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $699k 26,982 shares
Last Trade
May 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$209k 9,387 shares
$22.29
$25.92
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $456k 17,595 shares
Last Trade
Mar 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$89.7k 4,919 shares
$18.23
$25.92
Alector
Alector ALEC
Director
Holding Value $91.9k 61,250 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165k 35,000 shares
$4.70
$1.50
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.05M 15,542 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$593k 15,542 shares
$38.16
$67.71
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $414k 15,959 shares
Last Trade
May 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$233k 15,959 shares
$14.62
$25.92
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$97.3k 6,652 shares
$14.62
$25.92
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $584k 22,514 shares
Last Trade
May 29, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$97.3k 6,652 shares
$14.62
$25.92
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $0 0 shares
Last Trade
Mar 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$95.6k 2,092 shares
$45.69
$67.71

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up